Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited (D. Del. 2021)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-06-23 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 8,501,730 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited
Details for Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-07-26 | 61 | Opinion - Memorandum Opinion | terms in U.S. Patent Nos. 8,501,730 ("the '730 patent") and U.S. Patent No. 10,905,694…construction for multiple terms in U.S. Patent Nos. 8,501,730 and U.S. Patent No. 10,905,694. Signed by Judge …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification… A. The '730 Patent Claim 1 of the '730 patent is representative of the two | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |